NR1I2 and hepatocellular carcinoma: It has been described that PXR activation was protective in hepatocellular carcinoma (HCC), as evidenced by the fact that the PXR level was decreased in mice with HCC, while the migration, adhesion, and invasion were reduced in HepG2 cells transfected with PXR (84).